AMP EUROPE 2018
 

AMP EUROPE 2018

Achieving Dramatic Insights into Molecular Oncology & Precision Medicine

April 30–May 2, 2018
De Doelen ICC Rotterdam, The Netherlands

CONFERENCE DESCRIPTION/VISION: The emerging field of precision cancer medicine, in which the use of molecular data at the point of care directly impacts patient treatment and clinical decision-making, has already had a substantial, direct clinical impact on many aspects of medical oncology. The introduction of large-scale genomic technologies at the point of care has catalyzed discoveries in translational oncology and is driving new research that aims to dissect selective responses to targeted, immune-driven therapies and to chemotherapies, as well as identifying novel targets for which therapies are now in development. However, precision cancer medicine remains a promise rather than a solid and robust reality. Although the molecular landscapes of many cancers have been revealed using precision oncology approaches, many of the alterations observed in patients remain undruggable, and viable targets are incompletely characterized. In this conference we will discuss and address current advances, challenges and ignite solutions for the advancement of precision medicine.

Target Audience
  • Laboratory scientists, geneticists, researchers, physicians and technicians involved in oncology diagnostics and therapies
  • Professionals seeking to further their knowledge of advances in clinical molecular oncology
  • Professionals in medicine and industry who want to be a part of designing solutions to the challenges of precision medicine
Topics and Sessions

Topics

  • Recent Advances in Cell Free DNA
  • Evolution of Liquid Biopsies in Clinical Practice
  • Breakthroughs in Immunotherapies
  • Emerging Biomarkers and Their Role in Disease
  • Big Data: Challenges and Opportunities
  • Multi-omic Approaches to Disease
  • Quality & Harmonization: QC, PT and Reference Materials

Emerging Knowledge Sessions
These general sessions will feature presentations from prominent experts on topics at the forefront of molecular diagnostics, such as:

  • Recent Advances in Cell Free DNA
  • Evolution of Liquid Biopsies in Clinical Practice
  • Breakthroughs in Immunotherapies
  • Emerging Biomarkers and Their Role in Disease

Innovation Laboratory Sessions
These sessions are designed to be highly interactive, where attendees will share experiences, discuss, and propose solutions to specific challenges. Topics include:

  • Big Data: Challenges and Opportunities
  • Multi-omic Approaches to Disease
  • Quality & Harmonization: QC, PT and Reference Materials
 
 
 
Organizing Committee

Chair
Andrea Ferreira-Gonzalez, PhD, Virginia Commonwealth University, Richmond, USA

Vice Chair
Rami Mahfouz, MD, MPH, American University of Beirut Medical Center, Beirut, Lebanon

Members
Winand Dinjens, PhD, Erasmus MC, Rotterdam, Netherlands
Ernst-Jan Speel, PhD, Maastricht University Medical Center, Maastricht, Netherlands
Albrecht Stenzinger, MD, University Hospital Heidelberg, Heidelberg, Germany
Laura Tafe, MD, Dartmouth Hitchcock Medical Center, Lebanon, USA

 
Association of Molecular Pathology (AMP)

About AMP
The Association for Molecular Pathology (AMP) was founded in 1995 to provide structure and leadership to the emerging field of molecular diagnostics. AMP's 2,300+ members include individuals from academic and community medical centers, government, and industry; including pathologist and doctoral scientist laboratory directors; basic and translational scientists; technologists; and trainees. Through the efforts of its Board of Directors, Committees, Working Groups, and members, AMP is the primary resource for expertise, education, and collaboration in one of the fastest growing fields in healthcare. AMP members influence policy and regulation around the globe, ultimately serving to advance innovation in the field and protect patient access to high quality, appropriate testing.

Mission
The Association for Molecular Pathology is a not-for-profit scientific society that advances the clinical practice, science, and excellence of molecular and genomic laboratory medicine through education, innovation, and advocacy to enable highest quality health care.

How to Get Involved
AMP is the premier organization representing the needs and interests of the international molecular diagnostics community. AMP members receive a host of valuable benefits including access to our official publication, The Journal of Molecular Diagnostics, discounted registration fees for AMP sponsored events, instant access to experts in the field through AMP’s Members-Only community CHAMP, free access to many online learning materials, and a wide-variety of other resources and opportunities.

Join the global community of molecular pathology professionals and make AMP your professional home! To join visit: www.amp.org/join

 
AMP 2018
Contact us

Legal Organiser & PCO
MCI Deutschland GmbH
MCI | Germany – Berlin
Markgrafenstrasse 56
10117 Berlin, Germany
T: +49 30 204590
F: +49 30 2045950
amp-europe@mci-group.com

For questions concerning exhibition or sponsoring affairs, please contact:

Ms. Theresia Richter
T: +49 30 2045937
amp-sponsoring@mci-group.com

More information will follow shortly.


LEGAL NOTICE & DATA PRIVACY

Picture credit Rotterdamm skyline:
#169602248 © brichuas/Shutterstock.com